IDH1 and astrocytoma (excluding glioblastoma): In 2017, Venteicher et al. [137] combined scRNA-seq profiles from astrocytoma (IDH-A) and oligodendroglioma (IDH-O) tumors with 165 TCGA bulk RNA-seq profiles to analyze their genotype, phenotype, and the TME.